PRNewsWire
13 Jul 2026, 04:00 UTC · 12w ago
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB
Impact · against what's priced in
The receipt of a USD 60 million upfront payment and NMPA approval for ATG-201 provide a tangible liquidity boost and technical validation for Antengene. For UCB, the license secures a promising CD19/CD3 asset, though the impact is smaller relative to its scale.
- 6996.HK+0.70
No priced-in read yet
- In context
The company received a USD 60 million upfront payment and NMPA approval for its Phase I study of ATG-201, significantly improving its cash position and reducing technical risk for its lead asset.
Read from the article alone
